Adicet Bio ACET

$ 0.96 -1.23%

Quarterly report 2024-Q3
added 11-06-2024

Adicet Bio Balance Sheet 2011-2024 | ACET

Annual Balance Sheet Adicet Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-139 M	-237 M	-257 M	-62.7 M	-10.6 M	217 M	298 M	52 M	76.1 M	62.6 M	-1.16 M	20.9 M	26.3 M
Long Term Debt	17.7 M	18.5 M	19.4 M	-	-	303 M	339 M	119 M	100 M	97.2 M	20.4 M	39.1 M	6.25 M
Long Term Debt Current	3.22 M	2.49 M	1.57 M	1.22 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	21.5 M	127 M	369 M	408 M	134 M	108 M	109 M	33.8 M	52 M	6.25 M
Total Current Liabilities	19.3 M	19.7 M	16.3 M	22.5 M	12.2 M	5.72 M	-	-	-	-	-	-	-
Total Liabilities	37.1 M	38.4 M	35.8 M	44 M	142 M	672 M	633 M	236 M	236 M	234 M	129 M	131 M	151 M
Deferred Revenue	-	-	4.8 M	14 M	11 M	1.54 M	546 K	3.24 M	2.05 M	490 K	701 K	58 K	747 K
Retained Earnings	-381 M	-238 M	-168 M	-106 M	-69.6 M	-127 M	196 M	195 M	167 M	141 M	119 M	102 M	90.7 M
Total Assets	207 M	331 M	339 M	154 M	81.6 M	767 M	1.04 B	541 M	490 M	468 M	323 M	299 M	312 M
Cash and Cash Equivalents	160 M	258 M	278 M	84.3 M	33.8 M	7.04 M	53.3 M	-	-	-	-	-	-
Book Value	170 M	292 M	303 M	110 M	-60.4 M	95.3 M	405 M	304 M	254 M	234 M	195 M	168 M	161 M
Total Shareholders Equity	170 M	292 M	303 M	110 M	-60.4 M	104 M	-31.9 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Adicet Bio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	14.9 M	15.7 M	16.7 M	17.7 M	18.7 M	19.6 M	20.5 M	18.5 M	19.3 M	20.1 M	18.9 M	19.4 M	19.8 M	19.5 M	20 M	20.4 M	20.4 M	20.4 M	20.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	34.4 M	33.7 M	34.3 M	37.1 M	38.6 M	38.6 M	38.8 M	38.4 M	36.6 M	36.6 M	29.4 M	35.8 M	40 M	40.4 M	45.8 M	44 M	44 M	44 M	44 M	27.9 M	27.9 M	12.2 M	12.2 M	5.74 M	5.74 M	5.74 M	5.74 M	5.5 M	5.5 M	5.5 M	5.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	4.8 M	10.1 M	13.1 M	18 M	14 M	14 M	14 M	14 M	11 M	11 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-469 M	-439 M	-409 M	-381 M	-351 M	-301 M	-269 M	-238 M	-208 M	-186 M	-164 M	-168 M	-153 M	-138 M	-128 M	-106 M	-106 M	-106 M	-106 M	-69.6 M	-69.6 M	-154 M	-154 M	-71.4 M	-71.4 M	-71.4 M	-71.4 M	-33.8 M	-33.8 M	-33.8 M	-33.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	246 M	269 M	293 M	207 M	233 M	278 M	305 M	331 M	354 M	330 M	340 M	339 M	257 M	269 M	282 M	154 M	154 M	154 M	154 M	81.6 M	81.6 M	93.9 M	93.9 M	110 M	110 M	110 M	110 M	55.2 M	55.2 M	55.2 M	55.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	105 M	224 M	248 M	160 M	183 M	205 M	232 M	258 M	283 M	261 M	278 M	278 M	192 M	209 M	222 M	84.3 M	84.3 M	84.3 M	84.3 M	10.6 M	10.6 M	33.8 M	33.8 M	9.48 M	7.04 M	7.04 M	7.04 M	53.3 M	53.3 M	53.3 M	53.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	212 M	235 M	259 M	170 M	195 M	239 M	266 M	292 M	318 M	293 M	311 M	303 M	217 M	228 M	236 M	110 M	110 M	110 M	110 M	53.7 M	53.7 M	81.7 M	81.7 M	104 M	104 M	104 M	104 M	49.7 M	49.7 M	49.7 M	49.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	212 M	235 M	259 M	170 M	195 M	239 M	266 M	292 M	318 M	293 M	311 M	303 M	217 M	228 M	236 M	110 M	110 M	110 M	110 M	-60.4 M	-60.4 M	81.7 M	81.7 M	-33.5 M	104 M	104 M	104 M	-26.9 M	-31.9 M	-31.9 M	-31.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency